Company:  OSIRIS THERAPEUTICS, INC. (OSIR)
Form Type:  10-K
Filing Date:  3/26/2007 
CIK:  0001360886 
Address:  7015 ALBERT EINSTEIN DRIVE 
City, State, Zip:  COLUMBIA, Maryland 21046 
Telephone:  443-545-1819 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$10.70   		Change: 
-0.57 (-5.06%)  
Trade Time: 
May 20   		Market Cap: 
$352.37M
Description of Business
Register for a Free Trial and access this filing in:     
  FORM 10-K
    PART I
      Item 1. BUSINESS
        NAME AND TITLE
        NAME AND TITLE
      Item 2. PROPERTIES
      Item 3. LEGAL PROCEEDINGS
      Item 4. SUBMISSION OF MATTERS TO A VOTE OF ...
    PART II
      Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, ...
      Item 6. SELECTED FINANCIAL DATA
      Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF ...
        Results Of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures ...
      Item 8. Financial Statements and Supplementary Data
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO FINANCIAL STATEMENTS
      Item 9. Changes in and Disagreements with ...
      Item 9A. Controls and Procedures
      Item 9B. Other Information
    Part III
      Item 10. Directors, Executive Officers and Corporate ...
      Item 11. Executive Compensation.
      Item 12. Security Ownership of Certain Beneficial ...
      Item 13. Certain Relationships and Related ...
      Item 14. Principal Accountant Fees and Services.
    Part IV
      Item 15. Exhibits, Financial Statement Schedules.
    Report of Independent Registered Public Accounting Firm
    Signatures
  EXHIBIT 23.1.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 31.1.1
    Certification of Principal Executive Officer
  EXHIBIT 31.2.1
    Certification of Principal Financial Officer
  EXHIBIT 32.1.1
    Certification
© 1995-2013 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement